The firm is advancing its AI-driven multi-modal digital pathology platform as a tool for guiding clinical trial design and patient identification.

Imagene AI was founded in 2020 by CEO Dean Bitan, CDSO Jonathan Zalach and CTO Shahar Porat. The company uses a variety of ...

Imagene AI delivers a living intelligence engine for adaptive, insight-driven precision medicine. MIAMI, FL / ACCESS Newswire ...

NEW YORK – Drugmakers will soon be able to compete for a new accelerated review program established this week by the US Food and Drug Administration aimed at therapeutic programs that align with ...